Clinical trial

Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal…

NCT00015665 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed

Key facts

NCT number NCT00015665
Title Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections
Official title Open-Label, Non-Comparative Protocol for the Emergency Use of Voriconazole in Patients With Life Threatening, Invasive Mycoses Who Are Failing on Currently Available Antifungal Agents
Lead sponsor National Institute of Allergy and Infectious Diseases (NIAID), NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Mycoses
Intervention type Drug
Interventions Voriconazole
Enrollment 40
Start date Apr 1, 2001
Completion Mar 1, 2003
First posted Apr 30, 2001
Last update posted Mar 4, 2008
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies